Norges Bank Invests $1.62 Million in Teladoc Health, Inc. (NYSE:TDOC)

Norges Bank acquired a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 178,000 shares of the health services provider's stock, valued at approximately $1,618,000. Norges Bank owned 0.10% of Teladoc Health as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Y Intercept Hong Kong Ltd bought a new stake in Teladoc Health in the 3rd quarter valued at about $152,000. Geode Capital Management LLC boosted its holdings in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after buying an additional 56,864 shares during the period. TCW Group Inc. purchased a new position in Teladoc Health in the 3rd quarter valued at approximately $2,464,000. Versant Capital Management Inc lifted its position in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after acquiring an additional 2,441 shares in the last quarter. Finally, Smith Anglin Financial LLC bought a new position in shares of Teladoc Health in the fourth quarter worth $108,000. 76.82% of the stock is owned by institutional investors.

Insider Activity

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.95% of the company's stock.

Remove Ads

Teladoc Health Trading Down 0.6 %

Shares of Teladoc Health stock traded down $0.05 on Tuesday, hitting $7.20. The stock had a trading volume of 5,324,540 shares, compared to its average volume of 6,238,477. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a one year low of $6.61 and a one year high of $15.21. The stock's 50-day simple moving average is $9.66 and its two-hundred day simple moving average is $9.70. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -1.25 and a beta of 1.73.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Oppenheimer reduced their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Piper Sandler decreased their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group decreased their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Finally, Bank of America lowered their price objective on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $10.94.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.